Overview

Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet

Status:
Completed
Trial end date:
2018-10-12
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of CKD-495
Phase:
Phase 2
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Ethanol
Rebamipide